English | Español
English | Español
  • Insurance
  • Marketing
  • Pharmaceuticals
  • Technology/Innovation
  • Regulatory
  • Community

Weave Communications

+ Technology/Innovation
Patient Daily | May 7, 2023

Weave Launches AI-Driven Review Response Tool for Healthcare Providers

+ Community
Patient Daily | May 7, 2023

Weave Welcomes Marcus Bertilson as Chief Strategy & Services Officer

+ Community
Patient Daily | May 7, 2023

Weave Wins 3 Cultural Excellence Awards from Top Workplaces USA

+ Community
Patient Daily | Apr 24, 2023

Weave Communications, Inc. Announces Date of First Quarter 2023 Financial Results and Conference Call

+ Technology/Innovation
Patient Daily | Apr 24, 2023

Weave Adds 3 New Integrated Experiences for Veterinary Clinics

Trending

+ Pharmaceuticals
Patient Daily | Aug 4, 2026

Merck reports mixed results for tulisokibart in recent clinical trials and financial update

+ Pharmaceuticals
Patient Daily | Aug 6, 2026

FDA approves Replimune’s melanoma drug Tudriqev after advisory committee debate

+ Regulatory
M. R. Armstrong | Aug 4, 2026

Public Policy Solutions on 340B: 'The program has enriched big hospital execs'

+ Pharmaceuticals
Patient Daily | Aug 5, 2026

Bristol Myers Squibb and AstraZeneca reportedly in merger talks amid industry changes



Community
Insurance
Marketing
Pharmaceuticals
Regulatory
Technology/Innovation
About
Contact
© 2026 Patient Daily